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A 2,4,6-trialkylanilide-containing chiral diene has been 
identified as a superior ligand for the enantioselective rhodium-
catalyzed arylation of alkenylazaarenes with arylboronic acids.  
 
As part of a program aimed at the preparation of enantioenriched 
chiral azaarene-containing compounds,1 we have focused upon an 
underexploited strategy in asymmetric synthesis, namely the 
utilization of the C=N moiety within certain azaarenes to activate 
adjacent functionality in enantioselective catalysis.2–4 In this context, 
we have reported1b the enantioselective rhodium-catalyzed 1,4-
arylation5–8 of β-substituted alkenylazaarenes with arylboronic acids 
using a secondary amide-containing chiral diene9–11 ligand L1 (see 
Table 1, entry 1), which builds upon early studies by the groups of 
Lautens12a and Genet12b using vinylazaarenes. Although L1 was 
highly effective, it was of interest to determine whether a ligand of 
this complexity, possessing stereochemical elements additional to 
those of the chiral diene component, was actually necessary for 
optimal results.13 Herein, we report a simpler ligand that provides 
results superior to those obtained using L1, along with a more 
comprehensive evaluation of the scope of the reaction. 
 First, various analogues of L1 were prepared and evaluated in 
the enantioselective addition of 4-methylphenylboronic acid to 2-
alkenylquinoline 1a (Table 1), a reaction that gave 2a in 67% yield  
Table 1     Ligand evaluation for arylation of 1aa  
 
Entry Ligand X Conversion (%) ee (%) 
1b L1 
 
67% yield 92 
2 L2 NHCy >95 90 
3 L3 NCy2 28 59 
4 L4 NHBn >95 88 
5 L5 NBn2 81 85 
6 L6 NMe2 91 46 
7 L7 NHPh 58 76 
8 L8 NH(2,4,6-Me3C6H2) 33 96 
9 L9 NH[2,4,6-(i-Pr)3C6H2] >95 99 
a Reactions were conducted using 0.10 mmol of 1a (0.2 M). Conversions 
were determined by 1H NMR analysis of the unpurified reaction 
mixtures. Enantiomeric excesses were determined by chiral HPLC 
analysis. b Ref. 1b. 
 
and 92% ee in our original study.1b The conditions employed were 
identical to those we described previously.1b Ligand L2, which lacks 
the pyrrole moiety on the cyclohexane, provided 2a in high 
conversion but the enantioselectivity was slightly lower (entry 2) 
compared with that obtained using L1 (entry 1). However, the 
dicyclohexylamide L3 was noticeably inferior (entry 3). Ligands L4 
and L5, which contain one or two benzyl groups, respectively, 
provided reasonable results (entries 4 and 5), but the 
enantioselectivities were lower compared with L1. The 
dimethylamide L6 gave high conversion but the reaction was poorly  
Table 2     Comparison of ligand L9 with L1a 
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a Reactions were conducted using 0.50 mmol of alkenylazaarene (0.2 M). 
Yields are of isolated material. Enantiomeric excesses were determined by 
chiral HPLC analysis. b Results taken from ref.1b c Reaction conducted using 
0.30 mmol of alkenylazaarene. 
 
enantioselective (46% ee, entry 6). Next, ligands L7–L9 containing 
anilide groups were studied (entries 7–9), and of these, the 2,4,6-
triisopropylanilide L9 provided the best results, giving 2a in >95% 
conversion and 99% ee (entry 9). 
 Further confirmation of the superior enantioselectivities 
imparted by this new triisopropylanilide ligand L9 was provided by 
repeating representative reactions described in our original study1b 
using L9 in place of L1 (Table 2). These results indicate that while 
in most cases the isolated yields of the products with both ligands 
are comparable, the enantioselectivities are higher using L9 (2a, 2b, 
2c, 2e, and 2f). One exception was the addition of 4-
methylphenylboronic acid to a substrate containing a 4,5-
diphenyloxazole as the activating group, which gave 2d in 77% ee 
using L9, and this result is inferior to that obtained using ligand L1 
(89% ee). Interestingly, the inferiority of L9 compared with L1 with 
this substrate appeared to be restricted to the use of 4-
methylphenylboronic acid; when 3-methylphenylboronic acid was 
employed, L9 provided the product 2e in a higher enantioselectivity. 
The reasons for these contrasting results are not currently known. 
 To explore the scope of the process with the second generation 
ligand L9 more comprehensively, a range of previously reported and 
new alkenylazaarenes were reacted with 4-methylphenylboronic acid 
(Table 3). While substrates containing pyrimidine or benzoxazole, 
azaarenes that have already been demonstrated to be efficient 
activating groups in our original study,1b underwent arylation  
Table 3     Arylation of alkenylazaarenes with 4-methylphenylboronic acid 
 
 
a Reactions were conducted using 0.30 mmol of alkenylazaarene (0.2 M). 
Yields are of isolated material. Enantiomeric excesses were determined by 
chiral HPLC analysis. b Enantiomeric excess determined after hydrolysis to 
the secondary amide. c The stereochemistry of 2m was determined by X-ray 
crystallography, CCDC 976346. d The structure of the alkenylazaarene 
substrate 1m was determined by X-ray crystallography, CCDC 976345. 
 
efficiently with excellent enantioselectivities as expected (2g and 
2k), further examples demonstrate that other azaarenes are also 
effective. These examples include π-deficient azaarenes such as 
pyrazine (2h), a chloropyrimidine (2i), and a 4,6-bis(aryl)-1,3,5- 
triazine (2j), as well as π-excessive azaarenes such as benzothiazole 
(2l), a 1,3,4-oxadiazole (2m), and a tetrazole (2o). A pyrazine-
containing substrate was only moderately reactive, providing product 
2h in 48% yield, though in 99% ee. Although alkenyltetrazole 1l was 
unreactive (none of 2n was obtained), its regioisomer 1m provided 
2o in 64% yield and 95% ee. The difference in reactivities between 
1l and 1m can be understood by consideration of their conjugation 
patterns. Whereas the alkene is conjugated only with the C=N group 
of the tetrazole in 1l, it is conjugated with both the C=N and N=N  
 
 
Fig. 1    Difference in conjugation between alkenyltetrazoles 1l and 1m. 
Table 4     Arylation of alkenylazaarenes with various arylboronic acids 
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Entry Product  
Yield 
(%)b 
ee 
(%)c 
1 
2 
3  
2p  Ar = Ph 
2q  Ar = 2-MeC6H4 
2r  Ar = 4-FC6H4 
89 
>95 
78 
99 
97 
99 
4 
5 
 
2s Ar = 4-MeOC6H4 
2t  Ar = 3-EtO2C6H4 
82 
62 
98 
93d 
6 
7 
 
2u  Ar = 3,5-(F3C)2C6H3 
2v  Ar = 4-O2NC6H4 
92 
85 
96e  
94 
8 
9 
 
2w  Ar = 2-naphthyl  
2x  Ar = 3,5-Me2C6H3 
62 
85 
98 
99 
10 
 
2y  Ar = 3-Cl-4-i-PrOC6H3 63 99 
a Reactions were conducted using 0.30 mmol of alkenylazaarene (0.2 M). b 
Isolated yield. c Determined by chiral HPLC analysis. d Enantiomeric excess 
determined on a derivative obtained after treatment of 2t with LiOH in 
THF/MeOH/H2O. 
e Enantiomeric excess determined after demethylation of 
the methoxy groups using BBr3. 
 
moieties in 1m, leading to a greater degree of activation (Fig. 1). 
With respect to the β-substituent on the alkene, the process is 
tolerant of simple alkyl groups (2i and 2j), a cyclopropane (2h), an 
ether (2g), and aryl groups (2k, 2l, 2m, and 2o). 
A range of arylboronic acids are compatible with this process, as 
demonstrated by the results presented in Table 4. Arylboronic acids 
containing substituents such as methyl (entries 2 and 9), halogen 
(entries 3 and 10), or alkoxy (entries 4 and 10) groups reacted 
smoothly with various alkenylazaarenes in good yields and high 
enantioselectivities. Arylboronic acids containing strong electron-
withdrawing groups such as ester, trifluoromethyl, or even nitro 
substituents were also effective (entries 5–7). A sterically 
encumbering ortho-substituent on the arylboronic acid was also 
tolerated (entry 2).  
 This process can also be conducted on a larger scale using lower 
loadings of the arylboronic acid and catalyst. For example, arylation 
of alkenylpyrimidine 1h on a 5.0 mmol scale with 4-
methoxyphenylboronic acid (1.5 equiv), using thermal heating at 70  
 
 
°C in the presence of 2.0 mol% of the rhodium‒chiral diene 
complex, provided 2s in 75% yield (1.27 g) and 96% ee (eq 1). 
 In summary, a more in-depth evaluation of chiral diene ligands 
for the enantioselective addition of arylboronic acids to 
alkenylazaarenes has resulted in the identification of a second-
generation ligand L9 containing a 2,4,6-triisopropylanilide moiety 
that is superior to our first generation ligand L1. Not only does this 
new chiral diene result in generally superior enantioselectivities, it is 
simpler in structure. A more thorough assessment of the scope of the 
process demonstrated that the effectiveness of ligand L9 is fairly 
general across a range alkenylazaarenes and arylboronic acids. 
Further experimental and theoretical14 investigations of anilide-
containing chiral dienes in asymmetric catalysis are planned, and 
will be reported in due course. 
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